A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...
As hair thinning and skin aging continue to be prevalent concerns worldwide, VCare's latest GFC treatment has emerged as a ...
News Medical on MSN10h
New nanosystem offers hope for improved diagnosis and treatment of tongue cancerA pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...
GlobalData on MSN5d
FDA breakthrough status for Bluejay’s CHD therapy brelovitugThe US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently ...
News Medical on MSN3d
Breakthrough gene discovery offers new hope for medulloblastoma therapyScientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.
Brelovitug has previously received Orphan and PRIME designation from the European Medicines Agency.
What You Need to Know The global hydrogen water market is projected to grow from USD 2.5 billion in 2024 to USD 4.35 billion ...
Innovent Biologics, Inc., announced that the Center for Drug Evaluation (CDE) of China's National Medical Products ...
A revolutionary advancement in cancer treatment at UH Seidman Cancer Center is dramatically reducing the time patients spend ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback